BDBM573382 (R)-4-fluoro-3- ((1-(methyl- d3)pyrrolidin-2- yl)methyl-d2)- 1H-indole::US11453689, Compound I-37::US11453689, Compound I-40

SMILES CN1CCC[C@@H]1Cc1c[nH]c2cccc(F)c12

InChI Key InChIKey=ZXGSXBKTNNCUFJ-UHFFFAOYSA-N

Data  2 IC50  4 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 573382   

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573382(US11453689, Compound I-37 | US11453689, Compound I...)
Affinity DataIC50: 500nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573382(US11453689, Compound I-37 | US11453689, Compound I...)
Affinity DataEC50: <1.00E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573382(US11453689, Compound I-37 | US11453689, Compound I...)
Affinity DataEC50: <1.00E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573382(US11453689, Compound I-37 | US11453689, Compound I...)
Affinity DataEC50: <1.00E+3nMAssay Description:Agonist activity at human 5-HT2A receptor expressed in cells assessed as increase in calcium mobilization by Calcium-6 dye based FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573382(US11453689, Compound I-37 | US11453689, Compound I...)
Affinity DataEC50: <1.00E+3nMAssay Description:Agonist activity at human 5-HT2A receptor expressed in cells assessed as increase in calcium mobilization by Calcium-6 dye based FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573382(US11453689, Compound I-37 | US11453689, Compound I...)
Affinity DataIC50: 2.75E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent